Possible clinical outcome measures for clinical trials in patients with multiple sclerosis

Myla D. Goldman, Robert W. Motl, Richard A. Rudick

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Possible clinical outcome measures for clinical trials in patients with multiple sclerosis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience